Dino Di Carlo is the Armond and Elena Hairapetian Professor of Bioengineering at UCLA, serial entrepreneur and inventor. He serves in academic leadership roles as the Chair of the Bioengineering Department and Deputy Director of a National Science Foundation Engineering Research Center. He is an author on >200 peer-reviewed articles and an inventor on >80 issued patents in the U.S. and across the world. His research focuses on the interface between micro & nanotechnology, information technology, and the life sciences. He also has served in business leadership roles. He co-founded several companies in the diagnostics, medical device, and biotech/pharmaceutical industries and continues to serve on the board of directors of many of these companies, and as a scientific advisor and mentor to startups, including Cytovale, Tempo Therapeutics, and Partillion Bioscience. His inventions are incorporated into commercial medical devices, such as Cytovale's IntelliSepTM test, which is the first test approved by the FDA to detect sepsis early in the emergency department, and Tempo Therapeutics’ MAP Wound MatrixTM, which has shown efficacy in humans to regenerate tissue in large wounds. Other inventions from his lab scale and automate life science research, such as Nanovial technology from Partillion Bioscience, which allows antibody drug developers to rapidly discover new antibody sequences, accelerating life-saving drugs to the clinic. He has received numerous awards, including the Presidential Early Career Award for Scientists and Engineers (PECASE), the highest honor bestowed upon young scientists and engineers in the U.S.